undamentalytics Newsletter
Sign in

Sotera Health Co income statement

In fiscal 2025, Sotera Health Co reported revenue of $1.16bn, up 5.7% on the year before and net income of $77.9m, or $0.27 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue7788189311,0041,0491,1001,1641,216
Cost of revenue383375413447472498518548
Gross profit395444519557577602646669
Selling, general and administrative147179198246237243253257
Operating income184206257248277298——
Income before tax−1−39176−243106114148264
Income tax20−159−10556970101
Net income−21−39117−234514478163
Diluted EPS−$0.09−$0.16$0.41−$0.83$0.18$0.16$0.27$0.57
Diluted shares (average)232m238m279m280m283m285m286m288m
EBITDA250269321313353382——

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: SHC vs TECHRGEN vs SHCNEO vs SHC

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Sotera Health Co's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sotera Health Co.